&nbsp;

Jan 2025

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Chronic Myeloid (CML)

Intent: Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia, according to specific clinical criteria

Drugs Used:

ponatinib

Quick Link(s):

Regimen Monograph

Dec 2025

Regimen

PNAT

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative, Palliative

Funding:

Exceptional Access Program

ponatinib - For the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), according to specific clinical criteria

Drugs Used:

ponatinib

Quick Link(s):

Regimen Monograph

Dec 2025

Drug

ponatinib

Other Name(s): Iclusig®

Quick Link(s):

Dec 2025

Drug

pazopanib

Other Name(s): Votrient®

Quick Link(s):

Dec 2025

Drug

pamidronate

Quick Link(s):

Jan 2026

Drug

polatuzumab vedotin

Other Name(s): Polivy™

Quick Link(s):

Jan 2026

Regimen

PMDR

Cancer Type:

Breast

Intent: Palliative

Drugs Used:

pamidronate

Quick Link(s):

Regimen Monograph

Jan 2026

Regimen

PMDR

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

pamidronate

Quick Link(s):

Regimen Monograph

Jan 2026

Regimen

PMDR(HYPER CA)

Cancer Type:

Breast,

Central Nervous System,

Endocrine,

Gastrointestinal,

Genitourinary,

Gynecologic,

Head and Neck,

Hematologic,

Lung,

Sarcoma,

Skin,

Unknown Primary

Intent: Supportive Care, Palliative

Drugs Used:

pamidronate

Quick Link(s):

Regimen Monograph

Jan 2026

Regimen

PACL(W)+TRAS

Cancer Type:

Breast

Intent: Adjuvant

Funding:

New Drug Funding Program

Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer

Drugs Used:

PACLitaxel,

trastuzumab